Gilead Ties Up With Drugmakers In India, Pak For Making Remdesivir

Gilead Sciences Incsaid on Tuesday it has signed non-exclusive licensing pacts with five generic drugmakers based in India and Pakistan to expand the supply of its experimental COVID-19 treatment...

Read full article